ClinicalTrials.govpublic full text
Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE)
al amyloidosis, light chain (al) amyloidosis, systemic light chain disease, translocation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009149
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.